Baird Financial Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.11B Buy
4,524,578
+154,398
+4% +$36M 1.73% 11
2025
Q4
$904M Buy
4,370,180
+93,414
+2% +$18.5M 1.41% 14
2025
Q3
$793M Buy
4,276,766
+115,178
+3% +$19.7M 1.28% 17
2025
Q2
$636M Buy
4,161,588
+67,158
+2% +$10.3M 1.11% 18
2025
Q1
$679M Buy
4,094,430
+164,106
+4% +$25.7M 1.31% 13
2024
Q4
$568M Sell
3,930,324
-173,517
-4% -$26.9M 1.09% 15
2024
Q3
$665M Buy
4,103,841
+68,234
+2% +$10.9M 1.29% 12
2024
Q2
$590M Buy
4,035,607
+28,732
+0.7% +$4.27M 1.22% 13
2024
Q1
$634M Buy
4,006,875
+80,273
+2% +$12.8M 1.33% 12
2023
Q4
$615M Buy
3,926,602
+111,125
+3% +$17M 1.4% 9
2023
Q3
$594M Sell
3,815,477
-7,057
-0.2% -$1.16M 1.62% 9
2023
Q2
$633M Sell
3,822,534
-954,779
-20% -$154M 1.67% 9
2023
Q1
$740M Buy
4,777,313
+132,713
+3% +$21.4M 1.83% 7
2022
Q4
$820M Buy
4,644,600
+439,708
+10% +$75.9M 2.16% 5
2022
Q3
$687M Buy
4,204,892
+112,925
+3% +$19.1M 2.02% 3
2022
Q2
$726M Buy
4,091,967
+152,511
+4% +$27.2M 2.02% 3
2022
Q1
$698M Buy
3,939,456
+227,695
+6% +$38.7M 1.73% 6
2021
Q4
$635M Buy
3,711,761
+367,215
+11% +$60.1M 1.48% 9
2021
Q3
$540M Buy
3,344,546
+61,740
+2% +$10.5M 1.38% 11
2021
Q2
$541M Sell
3,282,806
-80,142
-2% -$13.3M 1.41% 11
2021
Q1
$553M Buy
3,362,948
+93,558
+3% +$15.1M 1.55% 8
2020
Q4
$515M Buy
3,269,390
+80,597
+3% +$11.9M 1.54% 7
2020
Q3
$475M Buy
3,188,793
+33,222
+1% +$4.92M 1.63% 7
2020
Q2
$444M Buy
3,155,571
+120,301
+4% +$17.5M 1.67% 5
2020
Q1
$398M Buy
3,035,270
+63,690
+2% +$9.04M 1.82% 5
2019
Q4
$433M Buy
2,971,580
+18,552
+0.6% +$2.52M 1.56% 7
2019
Q3
$382M Sell
2,953,028
-147,217
-5% -$19.4M 1.5% 9
2019
Q2
$432M Buy
3,100,245
+1,682,863
+119% +$233M 1.68% 5
2019
Q1
$198M Sell
1,417,382
-255,308
-15% -$34.2M 1.16% 7
2018
Q4
$216M Buy
1,672,690
+74,161
+5% +$10.3M 1.47% 7
2018
Q3
$223M Buy
1,598,529
+28,548
+2% +$3.79M 1.4% 7
2018
Q2
$191M Buy
1,569,981
+97,240
+7% +$12.1M 1.29% 7
2018
Q1
$189M Buy
1,472,741
+27,571
+2% +$3.73M 1.33% 7
2017
Q4
$202M Buy
1,445,170
+17,783
+1% +$2.48M 1.43% 7
2017
Q3
$186M Buy
1,427,387
+25,026
+2% +$3.32M 1.4% 6
2017
Q2
$186M Buy
1,402,361
+28,756
+2% +$3.67M 1.45% 6
2017
Q1
$171M Buy
1,373,605
+12,271
+0.9% +$1.47M 1.38% 6
2016
Q4
$157M Buy
1,361,334
+17,566
+1% +$2.03M 1.36% 8
2016
Q3
$159M Sell
1,343,768
-6,299
-0.5% -$764K 1.42% 7
2016
Q2
$164M Sell
1,350,067
-14,787
-1% -$1.68M 1.51% 6
2016
Q1
$148M Buy
1,364,854
+36,914
+3% +$3.82M 1.41% 8
2015
Q4
$136M Buy
1,327,940
+14,631
+1% +$1.47M 1.36% 8
2015
Q3
$123M Sell
1,313,309
-931
-0.1% -$90.1K 1.3% 6
2015
Q2
$128M Buy
+1,314,240
New +$132M 1.26% 7

Other funds holding JNJ

Baird Financial Group's JNJ Position: Q1 2026 in Review

Baird Financial Group increased its Johnson & Johnson (JNJ) stake by 3.5% in Q1 2026, buying an estimated $36M and bringing the position to 4,524,578 shares worth $1.11B. The position accounts for 1.73% of the portfolio, ranked #11.

Baird Financial Group first reported a position in JNJ in Q2 2015 and has held it in 44 quarters since. 4,627 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Baird Financial Group held 4,524,578 shares of Johnson & Johnson worth $1.11B as of Q1 2026.
  • Baird Financial Group bought 154,398 Johnson & Johnson shares in Q1 2026, an estimated $36M.
  • Johnson & Johnson made up 1.73% of Baird Financial Group's portfolio in Q1 2026, its #11 holding.
  • Baird Financial Group first reported a position in Johnson & Johnson in Q2 2015 and has held it in 44 quarters since.
  • 4,627 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Baird Financial Group's 13F filing for Q1 2026, filed 14 May 2026.